{"slideshow_credits": null, "snippet": "Roche's revised offer to acquire Illumina, a gene-sequencing technology company, for $51 per share was rejected unanimously by Illumina's board, the company announced Monday.", "abstract": "Roche's revised offer to acquire Illumina, a gene-sequencing technology company, for $51 per share was rejected unanimously by Illumina's board, the company announced Monday.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Kevin", "role": "reported", "lastname": "ROOSE", "rank": 1, "organization": ""}], "original": "By KEVIN ROOSE"}, "web_url": "http://dealbook.nytimes.com/2012/04/02/illumina-nixes-roches-revised-offer/", "lead_paragraph": null, "headline": {"main": "Illumina Nixes Roche's Revised Offer ", "kicker": "DealBook"}, "_id": "4fd3a3f28eb7c8105d8edf06", "word_count": "268", "multimedia": [], "pub_date": "2012-04-02T14:24:35Z", "source": "The New York Times", "news_desk": null, "keywords": [], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}